BioStock: Emplicure continues development work with Empli03

03 March 2023 - 08:45

After receiving results from the PKstudy with Empli03, Emplicure is now moving forward with the formulation development of the candidate. The company also recently initiated a collaboration with OnDosis to develop better pain treatments. BioStock  talked to CEO Håkan Engqvist.

Read the full article about Emplicure at

This is a press release from BioStock – Connecting Innovation & Capital.

Provided by: Cision
Nasdaq First North GM Stockholm (Sweden)
Emplicure AB
Emplicure is a pharmaceutical company that develops new innovative drugs based on the combination of already approved active substances and advanced materials science in bioceramics. The product portfolio initially focuses on drugs for chronic pain and with addictive properties....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More